Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial
| Image |  |
|---|---|
| Description | scientific article published on 30 March 2018 |
| Author/s |
author: Peter Bossuyt |
| Publication date | March 30, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |